Cerebellum’s Enovis ENOV Stock Holding History

Cerebellum’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$66K	Buy	1,220 +14	+1%	+$769	0.31%	23
2020 Q2	$82K	Buy	+1,206	New	+$53.3K	0.06%	354
2019 Q4	$244K	Buy	+3,891	New	+$220K	0.13%	352
2018 Q1	–	Sell	-1,206	Closed	-$82K	–	471
2017 Q4	$82K	Buy	+1,206	New	+$81.2K	0.06%	354

Other funds holding ENOV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Cerebellum's ENOV Position: Q3 2020 in Review

Cerebellum increased its Enovis (ENOV) stake by 1.2% in Q3 2020, buying an estimated $769 and bringing the position to 1,220 shares worth $66K. The position accounts for 0.31% of the portfolio, ranked #23.

Cerebellum first reported a position in ENOV in Q4 2017 and has held it in 4 quarters since. The position peaked at $244K in Q4 2019. 262 funds tracked by Wall St. Rank hold ENOV as of Q3 2020.

Cerebellum held 1,220 shares of Enovis worth $66K as of Q3 2020.
Cerebellum bought 14 Enovis shares in Q3 2020, an estimated $769.
Enovis made up 0.31% of Cerebellum's portfolio in Q3 2020, its #23 holding.
Cerebellum first reported a position in Enovis in Q4 2017 and has held it in 4 quarters since.
Cerebellum's Enovis position peaked at $244K in Q4 2019.
262 funds tracked by Wall St. Rank held Enovis as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.